LF
ABBV icon

LifeSteps Financial’s AbbVie ABBV Stock Holding History

LifeSteps Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
7,339
+51
+0.7% +$11K 0.86% 21
2026
Q1 		$1.59M Sell
7,288
-41
-0.6% -$9.1K 1% 20
2025
Q4 		$1.67M Buy
7,329
+13
+0.2% +$2.96K 1.07% 19
2025
Q3 		$1.69M Sell
7,316
-42
-0.6% -$8.55K 1.09% 20
2025
Q2 		$1.37M Buy
7,358
+54
+0.7% +$10K 0.94% 23
2025
Q1 		$1.53M Buy
7,304
+71
+1% +$13.8K 1.24% 21
2024
Q4 		$1.29M Sell
7,233
-186
-3% -$34.2K 0.99% 24
2024
Q3 		$1.47M Buy
7,419
+95
+1% +$17.7K 1.15% 22
2024
Q2 		$1.26M Sell
7,324
-41
-0.6% -$6.79K 1.04% 22
2024
Q1 		$1.34M Sell
7,365
-59
-0.8% -$10.2K 1.01% 22
2023
Q4 		$1.15M Buy
7,424
+15
+0.2% +$2.19K 1.02% 23
2023
Q3 		$1.1M Buy
7,409
+6
+0.1% +$881 1.12% 23
2023
Q2 		$997K Sell
7,403
-13
-0.2% -$1.91K 0.99% 23
2023
Q1 		$1.18M Sell
7,416
-66
-0.9% -$10.1K 1.25% 21
2022
Q4 		$1.21M Buy
7,482
+166
+2% +$25.5K 1.26% 20
2022
Q3 		$982K Buy
7,316
+304
+4% +$43.6K 1.11% 21
2022
Q2 		$1.07M Sell
7,012
-579
-8% -$88.5K 1.12% 20
2022
Q1 		$1.23M Buy
7,591
+210
+3% +$30.5K 0.91% 26
2021
Q4 		$999K Sell
7,381
-309
-4% -$36.5K 0.71% 28
2021
Q3 		$829K Buy
7,690
+132
+2% +$15.1K 0.63% 31
2021
Q2 		$851K Buy
7,558
+1,230
+19% +$139K 0.65% 31
2021
Q1 		$685K Buy
6,328
+1,526
+32% +$163K 0.57% 33
2020
Q4 		$515K Buy
4,802
+237
+5% +$22.8K 0.47% 37
2020
Q3 		$400K Buy
4,565
+2
+0% +$188 0.42% 43
2020
Q2 		$448K Buy
4,563
+1,072
+31% +$94.4K 0.52% 37
2020
Q1 		$266K Buy
3,491
+400
+13% +$34.1K 0.31% 61
2019
Q4 		$274K Buy
+3,091
New +$257K 0.26% 75

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

LifeSteps Financial's ABBV Position: Q2 2026 in Review

LifeSteps Financial increased its AbbVie (ABBV) stake by 0.7% in Q2 2026, buying an estimated $11K and bringing the position to 7,339 shares worth $1.85M. The position accounts for 0.86% of the portfolio, ranked #21.

LifeSteps Financial first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LifeSteps Financial held 7,339 shares of AbbVie worth $1.85M as of Q2 2026.
  • LifeSteps Financial bought 51 AbbVie shares in Q2 2026, an estimated $11K.
  • AbbVie made up 0.86% of LifeSteps Financial's portfolio in Q2 2026, its #21 holding.
  • LifeSteps Financial first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.